Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Linaclotide in chronic constipation
NCT00402337Phase 2Completed
- Sponsor
- Ironwood Pharmaceuticals
- Start
- Nov 2006
- Primary completion
- Dec 2007
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of linaclotide in chronic constipation (5 arms), sponsored by Ironwood Pharmaceuticals. Primary endpoint: Change From Pretreatment in Weekly Normalized Spontaneous Bowel Movement (SBM) Frequency at 4 weeks. Started Nov 2006; status: completed.
02
Drugs
linaclotide
03
Conditions
chronic constipation
Beyond the preview
Go deeper on NCT00402337.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00402337.